LD-2 disclosure · 3rd Quarter - Report

ALTRIA CLIENT SERVICES LLC

3rd Quarter (July 1 - Sep 30) · 2023Posted Oct 20, 2023Filing document ↗LDA record ↗

Expenses$2.7Mself-filed spend

Client

5 issues

Budget/Appropriations
HR 4368/S 2131 FY 2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill; provisions related to FDA rulemaking and enforcement efforts related to illicit electronic nicotine delivery systems (ENDS) products
LobbyistsJOHN HOEL · TODD WALKER · PHIL PARK · MICHELLE DIMAROB · JENNIFER A KANE · JOHN MASON · ANGELA ARBOLEDA · JILIAN SOUZA
TargetedSENATE · HOUSE OF REPRESENTATIVES
Government Issues
Discussions in support of the establishment of a comprehensive federal regulatory framework for cannabis Discussions concerning federal appropriations policy related to Food and Drug Administration clarity on CBD
LobbyistsTODD WALKER · PHIL PARK · MICHELLE DIMAROB · ANGELA ARBOLEDA · JILIAN SOUZA
TargetedSENATE · HOUSE OF REPRESENTATIVES
Labor Issues/Antitrust/Workplace
HJRes 59 and SJRes 25 A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Labor relating to "Adverse Effect Wage Rate Methodology for the Temporary Employment of H-2A Nonimmigrants in Non-Range Occupations in the United States"

LD-2 disclosure · 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) · 2023Posted Oct 20, 2023Filing document ↗LDA record ↗

Expenses$2.7Mself-filed spend

5 issues

Budget/Appropriations
HR 4368/S 2131 FY 2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill; provisions related to FDA rulemaking and enforcement efforts related to illicit electronic nicotine delivery systems (ENDS) products
LobbyistsJOHN HOEL · TODD WALKER · PHIL PARK · MICHELLE DIMAROB · JENNIFER A KANE · JOHN MASON · ANGELA ARBOLEDA · JILIAN SOUZA
TargetedSENATE · HOUSE OF REPRESENTATIVES
Government Issues
Discussions in support of the establishment of a comprehensive federal regulatory framework for cannabis Discussions concerning federal appropriations policy related to Food and Drug Administration clarity on CBD
LobbyistsTODD WALKER · PHIL PARK · MICHELLE DIMAROB · ANGELA ARBOLEDA · JILIAN SOUZA
TargetedSENATE · HOUSE OF REPRESENTATIVES
Labor Issues/Antitrust/Workplace
HJRes 59 and SJRes 25 A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Labor relating to "Adverse Effect Wage Rate Methodology for the Temporary Employment of H-2A Nonimmigrants in Non-Range Occupations in the United States"